The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Multi-Stakeholder Workshop / April 2021

Endpoints in Cancer Drug Development

26 – 27 April 2021, Amsterdam (Netherlands)

 

MEETING OBJECTIVES

  • Address the current challenges with surrogate endpoints in drug development and commercialisation
  • Focus on a problem-solving aspect through debates and multi-stakeholder panel discussions.

PROGRAMME COMMITTEE

  • Axel Glasmacher (CDDF, DE)
  • Ralf Herold (EMA, NL)
  • Chitkala Kalidas (Bayer, US)
  • Claudia Hey (Merck Healthcare KGaA, DE)

TARGET AUDIENCE

The target is a multidisciplinary audience of academia representatives, EU and US regulatory bodies (EMA, FDA, National Agencies), pharmaceutical Industry, HTAs and patient advocates.

DRAFT PROGRAMME 

View the draft programme HERE

MEETING DATE

26 – 27 April 2021

MEETING VENUE 

TBC (Amsterdam, NL)

 

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70